136 related articles for article (PubMed ID: 38565110)
21. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
22. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
[TBL] [Abstract][Full Text] [Related]
23. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
24. Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study.
Landy R; Haber G; Graubard BI; Campos NG; Sy S; Kim JJ; Burger EA; Cheung LC; Katki HA; Gillison ML; Chaturvedi AK
J Natl Cancer Inst; 2023 Apr; 115(4):429-436. PubMed ID: 36655795
[TBL] [Abstract][Full Text] [Related]
25. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.
Arya SC; Agarwal N
Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098
[No Abstract] [Full Text] [Related]
26. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
27. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
29. The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
Nauta IH; Heideman DAM; Brink A; van der Steen B; Bloemena E; Koljenović S; Baatenburg de Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2021 Jul; 149(2):420-430. PubMed ID: 33634865
[TBL] [Abstract][Full Text] [Related]
30. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.
Lehtinen M; Apter D; Eriksson T; Harjula K; Hokkanen M; Lehtinen T; Natunen K; Damaso S; Soila M; Bi D; Struyf F
Int J Cancer; 2020 Jul; 147(1):170-174. PubMed ID: 31736068
[TBL] [Abstract][Full Text] [Related]
32. HPV vaccine is needed.
Farley H
Minn Med; 2012 Jan; 95(1):6. PubMed ID: 22355900
[No Abstract] [Full Text] [Related]
33. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
34. Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.
Clark J; Jeffery CC; Zhang H; Cooper T; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):37. PubMed ID: 26374294
[TBL] [Abstract][Full Text] [Related]
35. HPV Vaccine Slashes Rates of Oral Infection.
Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738
[TBL] [Abstract][Full Text] [Related]
36. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.
Steinau M; Saraiya M; Goodman MT; Peters ES; Watson M; Cleveland JL; Lynch CF; Wilkinson EJ; Hernandez BY; Copeland G; Saber MS; Hopenhayn C; Huang Y; Cozen W; Lyu C; Unger ER;
Emerg Infect Dis; 2014 May; 20(5):822-8. PubMed ID: 24751181
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of HPV Related Malignancies.
Scott-Wittenborn N; Fakhry C
Semin Radiat Oncol; 2021 Oct; 31(4):286-296. PubMed ID: 34455984
[TBL] [Abstract][Full Text] [Related]
39. Roles of Human Papillomaviruses and p16 in Oral Cancer.
Sritippho T; Chotjumlong P; Iamaroon A
Asian Pac J Cancer Prev; 2015; 16(15):6193-200. PubMed ID: 26434816
[TBL] [Abstract][Full Text] [Related]
40. Rates and determinants of oral human papillomavirus infection in young men.
Edelstein ZR; Schwartz SM; Hawes S; Hughes JP; Feng Q; Stern ME; O'Reilly S; Lee SK; Fu Xi L; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):860-7. PubMed ID: 23064535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
